- Home
- Publications
- Publication Search
- Publication Details
Title
Are Integrins Still Practicable Targets for Anti-Cancer Therapy?
Authors
Keywords
-
Journal
Cancers
Volume 11, Issue 7, Pages 978
Publisher
MDPI AG
Online
2019-07-12
DOI
10.3390/cancers11070978
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The functional role of integrins during intra- and extravasation within the metastatic cascade
- (2019) Greta Sökeland et al. Molecular Cancer
- Targeting Alterations in the RAF–MEK Pathway
- (2019) Rona Yaeger et al. Cancer Discovery
- Integrin Signaling in Cancer: Mechanotransduction, Stemness, Epithelial Plasticity, and Therapeutic Resistance
- (2019) Jonathan Cooper et al. CANCER CELL
- Integrin Regulation of CAF Differentiation and Function
- (2019) C. Michael DiPersio et al. Cancers
- Integrins, CAFs and Mechanical Forces in the Progression of Cancer
- (2019) Imjoo Jang et al. Cancers
- Targeting the integrin interactome in human disease
- (2018) Miguel Vicente-Manzanares et al. CURRENT OPINION IN CELL BIOLOGY
- Conjugates of Cell Adhesion Peptides for Therapeutics and Diagnostics Against Cancer and Autoimmune Diseases
- (2018) Mario E.G. Moral et al. CURRENT TOPICS IN MEDICINAL CHEMISTRY
- Extracellular matrix internalization links nutrient signalling to invasive migration
- (2018) Elena Rainero INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY
- Targeted thermal therapy with genetically engineered magnetite magnetosomes@RGD: Photothermia is far more efficient than magnetic hyperthermia
- (2018) Anouchka Plan Sangnier et al. JOURNAL OF CONTROLLED RELEASE
- RGD peptide-based non-viral gene delivery vectors targeting integrin αvβ3 for cancer therapy
- (2018) Shuang Fu et al. JOURNAL OF DRUG TARGETING
- cRGD functionalised nanocarriers for targeted delivery of bioactives
- (2018) K. R. Gajbhiye et al. JOURNAL OF DRUG TARGETING
- Receptor tyrosine kinases and downstream pathways as druggable targets for cancer treatment: the current arsenal of inhibitors
- (2018) Wagner Ricardo Montor et al. Molecular Cancer
- Precise targeting of cancer metastasis using multi-ligand nanoparticles incorporating four different ligands
- (2018) P. M. Peiris et al. Nanoscale
- What about α v β 3 integrins in molecular imaging in oncology?
- (2018) Frederic Debordeaux et al. NUCLEAR MEDICINE AND BIOLOGY
- PKB/Akt-dependent regulation of inflammation in cancer
- (2018) Fengyuan Tang et al. SEMINARS IN CANCER BIOLOGY
- Autophagy promotes the survival of dormant breast cancer cells and metastatic tumour recurrence
- (2018) Laura Vera-Ramirez et al. Nature Communications
- Fluorescence imaging of invasive head and neck carcinoma cells with integrin αvβ6-targeting RGD-peptides: an approach to a fluorescence-assisted intraoperative cytological assessment of bony resection margins
- (2018) M. Nieberler et al. BRITISH JOURNAL OF ORAL & MAXILLOFACIAL SURGERY
- Dormancy in cancer
- (2018) Hiroko Endo et al. CANCER SCIENCE
- Role of Extracellular Matrix in Development and Cancer Progression
- (2018) Cameron Walker et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Integrin activation by talin, kindlin and mechanical forces
- (2018) Zhiqi Sun et al. NATURE CELL BIOLOGY
- RGD-modified polymer and liposome nanovehicles: Recent research progress for drug delivery in cancer therapeutics
- (2018) Yu Cheng et al. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
- Integrins and Cell Metabolism: An Intimate Relationship Impacting Cancer
- (2017) Rehman Ata et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- The Interconnections between Autophagy and Integrin-Mediated Cell Adhesion
- (2017) Ariadne Vlahakis et al. JOURNAL OF MOLECULAR BIOLOGY
- Acquired tumor resistance to antiangiogenic therapy: Mechanisms at a glance
- (2017) ShaghayeghHaghjooy Javanmard et al. Journal of Research in Medical Sciences
- A liver microphysiological system of tumor cell dormancy and inflammatory responsiveness is affected by scaffold properties
- (2017) A. M. Clark et al. LAB ON A CHIP
- Integrin-targeted peptide- and peptidomimetic-drug conjugates for the treatment of tumors
- (2017) Daniela Arosio et al. Recent Patents on Anti-Cancer Drug Discovery
- Multiple biological functions of Twist1 in various cancers
- (2017) Zhixiang Zhao et al. Oncotarget
- Exploring the Role of RGD-Recognizing Integrins in Cancer
- (2017) Markus Nieberler et al. Cancers
- Can Integrin Agonists Have Cards to Play against Cancer? A Literature Survey of Small Molecules Integrin Activators
- (2017) Alessandra Tolomelli et al. Cancers
- Epidermal Growth Factor Receptor Cell Proliferation Signaling Pathways
- (2017) et al. Cancers
- Advancement in integrin facilitated drug delivery
- (2016) Daniela Arosio et al. ADVANCED DRUG DELIVERY REVIEWS
- Homing to solid cancers: a vascular checkpoint in adoptive cell therapy using CAR T-cells
- (2016) Ann Ager et al. BIOCHEMICAL SOCIETY TRANSACTIONS
- 99mTc-HisoDGR as a Potential SPECT Probe for Orthotopic Glioma Detection via Targeting of Integrin α5β1
- (2016) Haitao Zhao et al. BIOCONJUGATE CHEMISTRY
- The complexity of integrins in cancer and new scopes for therapeutic targeting
- (2016) Hellyeh Hamidi et al. BRITISH JOURNAL OF CANCER
- The role of integrins in TGFβ activation in the tumour stroma
- (2016) Zareen Khan et al. CELL AND TISSUE RESEARCH
- Differential Effect on Bone Lesions of Targeting Integrins: Randomized Phase II Trial of Abituzumab in Patients with Metastatic Castration-Resistant Prostate Cancer
- (2016) M. Hussain et al. CLINICAL CANCER RESEARCH
- Mechanosensitivity of integrin adhesion complexes: role of the consensus adhesome
- (2016) Edward R. Horton et al. EXPERIMENTAL CELL RESEARCH
- Synergistic active targeting of dually integrin α v β 3 /CD44-targeted nanoparticles to B16F10 tumors located at different sites of mouse bodies
- (2016) Sanjun Shi et al. JOURNAL OF CONTROLLED RELEASE
- Joint Antiangiogenic Effect of ATN-161 and Anti-VEGF Antibody in a Rat Model of Early Wet Age-Related Macular Degeneration
- (2016) Wen-Qiu Wang et al. MOLECULAR PHARMACEUTICS
- Highly Expressed Integrin-α8 Induces Epithelial to Mesenchymal Transition-Like Features in Multiple Myeloma with Early Relapse
- (2016) Jiyeon Ryu et al. MOLECULES AND CELLS
- Molecularly Targeted Drugs Plus Radiotherapy and Temozolomide Treatment for Newly Diagnosed Glioblastoma: A Meta-Analysis and Systematic Review
- (2016) Jiahao Su et al. ONCOLOGY RESEARCH
- Control of YAP/TAZ Activity by Metabolic and Nutrient-Sensing Pathways
- (2016) Giulia Santinon et al. TRENDS IN CELL BIOLOGY
- Corrigendum: Beta 1-integrin–c-Met cooperation reveals an inside-in survival signalling on autophagy-related endomembranes
- (2016) Rachel Barrow-McGee et al. Nature Communications
- Integrin α7 is a functional cancer stem cell surface marker in oesophageal squamous cell carcinoma
- (2016) Xiao-Yan Ming et al. Nature Communications
- The matricellular protein CYR61 promotes breast cancer lung metastasis by facilitating tumor cell extravasation and suppressing anoikis
- (2016) Yu-Ting Huang et al. Oncotarget
- Cilengitide in newly diagnosed glioblastoma: biomarker expression and outcome
- (2016) Michael Weller et al. Oncotarget
- Clinical Application of Radiolabeled RGD Peptides for PET Imaging of Integrin αvβ3
- (2016) Haojun Chen et al. Theranostics
- Cell surface receptors for CCN proteins
- (2016) Lester F. Lau Journal of Cell Communication and Signaling
- Spatiotemporal Targeting of a Dual-Ligand Nanoparticle to Cancer Metastasis
- (2015) Elizabeth Doolittle et al. ACS Nano
- Stable Peptides Instead of Stapled Peptides: Highly Potent αvβ6-Selective Integrin Ligands
- (2015) Oleg V. Maltsev et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Cilengitide combined with cetuximab and platinum-based chemotherapy as first-line treatment in advanced non-small-cell lung cancer (NSCLC) patients: results of an open-label, randomized, controlled phase II study (CERTO)
- (2015) J. Vansteenkiste et al. ANNALS OF ONCOLOGY
- Identification of a PEAK1/ZEB1 signaling axis during TGFβ/fibronectin-induced EMT in breast cancer
- (2015) Megan Agajanian et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Interaction of kindlin-2 with integrin 3 promotes outside-in signaling responses by the V 3 vitronectin receptor
- (2015) Z. Liao et al. BLOOD
- Twist1 and AP-1 cooperatively upregulate integrin α5 expression to induce invasion and the epithelial–mesenchymal transition
- (2015) Eun-Hee Nam et al. CARCINOGENESIS
- In vivo biokinetic and metabolic characterization of the 68Ga-labelled α5β1-selective peptidomimetic FR366
- (2015) Calogero D’Alessandria et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Tumour exosome integrins determine organotropic metastasis
- (2015) Ayuko Hoshino et al. NATURE
- The evolutionary history of lethal metastatic prostate cancer
- (2015) Gunes Gundem et al. NATURE
- The hypoxic cancer secretome induces pre-metastatic bone lesions through lysyl oxidase
- (2015) Thomas R. Cox et al. NATURE
- Integrin endosomal signalling suppresses anoikis
- (2015) Jonna Alanko et al. NATURE CELL BIOLOGY
- Current status and future directions of anti-angiogenic therapy for gliomas
- (2015) Wolfgang Wick et al. NEURO-ONCOLOGY
- Two cilengitide regimens in combination with standard treatment for patients with newly diagnosed glioblastoma and unmethylated MGMT gene promoter: results of the open-label, controlled, randomized phase II CORE study
- (2015) L. Burt Nabors et al. NEURO-ONCOLOGY
- Integrins and cancer: regulators of cancer stemness, metastasis, and drug resistance
- (2015) Laetitia Seguin et al. TRENDS IN CELL BIOLOGY
- Fibroblast surface-associated FGF-2 promotes contact-dependent colorectal cancer cell migration and invasion through FGFR-SRC signaling and integrin αvβ5-mediated adhesion
- (2015) Sarah Knuchel et al. Oncotarget
- Twist promotes reprogramming of glucose metabolism in breast cancer cells through PI3K/AKT and p53 signaling pathways
- (2015) Li Yang et al. Oncotarget
- Medical management of lung cancer: Experience in China
- (2015) Yuankai Shi et al. Thoracic Cancer
- Abituzumab combined with cetuximab plus irinotecan versus cetuximab plus irinotecan alone for patients withKRASwild-type metastatic colorectal cancer: the randomised phase I/II POSEIDON trial
- (2014) E. Élez et al. ANNALS OF ONCOLOGY
- Cisplatin, 5-fluorouracil, and cetuximab (PFE) with or without cilengitide in recurrent/metastatic squamous cell carcinoma of the head and neck: results of the randomized phase I/II ADVANTAGE trial (phase II part)
- (2014) J. B. Vermorken et al. ANNALS OF ONCOLOGY
- Biogenesis, Secretion, and Intercellular Interactions of Exosomes and Other Extracellular Vesicles
- (2014) Marina Colombo et al. Annual Review of Cell and Developmental Biology
- Disruption of integrin–fibronectin complexes by allosteric but not ligand-mimetic inhibitors
- (2014) A. Paul Mould et al. BIOCHEMICAL JOURNAL
- Redefining the role(s) of endothelial αvβ3-integrin in angiogenesis: Figure 1
- (2014) Samuel J. Atkinson et al. BIOCHEMICAL SOCIETY TRANSACTIONS
- Spontaneous dormancy of metastatic breast cancer cells in an all human liver microphysiologic system
- (2014) S E Wheeler et al. BRITISH JOURNAL OF CANCER
- Dihydropyrimidine Accumulation Is Required for the Epithelial-Mesenchymal Transition
- (2014) Yoav D. Shaul et al. CELL
- Integrin αvβ3 Drives Slug Activation and Stemness in the Pregnant and Neoplastic Mammary Gland
- (2014) Jay S. Desgrosellier et al. DEVELOPMENTAL CELL
- Elongation factor-2 kinase regulates TG2/β1 integrin/Src/uPAR pathway and epithelial-mesenchymal transition mediating pancreatic cancer cells invasion
- (2014) Ahmed A. Ashour et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Cilengitide combined with standard treatment for patients with newly diagnosed glioblastoma with methylated MGMT promoter (CENTRIC EORTC 26071-22072 study): a multicentre, randomised, open-label, phase 3 trial
- (2014) Roger Stupp et al. LANCET ONCOLOGY
- Cilengitide in glioblastoma: when did it fail?
- (2014) Olivier L Chinot LANCET ONCOLOGY
- An integrin β3–KRAS–RalB complex drives tumour stemness and resistance to EGFR inhibition
- (2014) Laetitia Seguin et al. NATURE CELL BIOLOGY
- Regulated Splicing of the α6 Integrin Cytoplasmic Domain Determines the Fate of Breast Cancer Stem Cells
- (2014) Hira Lal Goel et al. Cell Reports
- H-CRRETAWAC-OH, a Lead Structure for the Development of Radiotracer Targeting Integrinα5β1?
- (2014) Roland Haubner et al. Biomed Research International
- Anoikis molecular pathways and its role in cancer progression
- (2013) Paolo Paoli et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- Preclinical recapitulation of antiangiogenic drug clinical efficacies using models of early or late stage breast cancer metastatis
- (2013) Robert S. Kerbel et al. BREAST
- A Rare Population of CD24+ITGB4+Notchhi Cells Drives Tumor Propagation in NSCLC and Requires Notch3 for Self-Renewal
- (2013) Yanyan Zheng et al. CANCER CELL
- The relevance of the TGF-β Paradox to EMT-MET programs
- (2013) Chevaun D. Morrison et al. CANCER LETTERS
- 1 Integrin: Critical Path to Antiangiogenic Therapy Resistance and Beyond
- (2013) A. Jahangiri et al. CANCER RESEARCH
- Stromally Derived Lysyl Oxidase Promotes Metastasis of Transforming Growth Factor- -Deficient Mouse Mammary Carcinomas
- (2013) M. W. Pickup et al. CANCER RESEARCH
- Erlotinib Resistance in Lung Cancer Cells Mediated by Integrin 1/Src/Akt-Driven Bypass Signaling
- (2013) R. Kanda et al. CANCER RESEARCH
- Mechanisms Governing Metastatic Dormancy and Reactivation
- (2013) Filippo G. Giancotti CELL
- Acute Depletion of Endothelial β3-Integrin Transiently Inhibits Tumor Growth and Angiogenesis in Mice
- (2013) Veronica Steri et al. CIRCULATION RESEARCH
- Development of RGD-Based Radiotracers for Tumor Imaging and Therapy: Translating from Bench to Bedside
- (2013) Z. Liu et al. CURRENT MOLECULAR MEDICINE
- GLI1 finds a new role in cancer stem cell biology
- (2013) Martin E. Fernandez-Zapico EMBO Molecular Medicine
- A Multicenter Phase 1 Study of EMD 525797 (DI17E6), a Novel Humanized Monoclonal Antibody Targeting αv Integrins, in Progressive Castration-resistant Prostate Cancer with Bone Metastases After Chemotherapy
- (2013) Manfred Wirth et al. EUROPEAN UROLOGY
- Integrin modulators: a patent review
- (2013) Tobias G Kapp et al. EXPERT OPINION ON THERAPEUTIC PATENTS
- CD49f-positive cell population efficiently enriches colon cancer-initiating cells
- (2013) NAOTSUGU HARAGUCHI et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Combined SFK/MEK inhibition prevents metastatic outgrowth of dormant tumor cells
- (2013) Lara H. El Touny et al. JOURNAL OF CLINICAL INVESTIGATION
- Cancer stem cells: The challenges ahead
- (2013) Jan Paul Medema NATURE CELL BIOLOGY
- Extracellular vesicles: biology and emerging therapeutic opportunities
- (2013) Samir EL Andaloussi et al. NATURE REVIEWS DRUG DISCOVERY
- Evaluation of the expression of stem cell markers in human breast cancer reveals a correlation with clinical progression and metastatic disease in ductal carcinoma
- (2013) TRACEY AMANDA MARTIN et al. ONCOLOGY REPORTS
- Validation of stem cell markers in clinical prostate cancer: α6-Integrin is predictive for non-aggressive disease
- (2013) A. Marije Hoogland et al. PROSTATE
- Inactivation of the Hippo tumour suppressor pathway by integrin-linked kinase
- (2013) Isabel Serrano et al. Nature Communications
- Integrins and metastasis
- (2013) Kirat Kumar Ganguly et al. Cell Adhesion & Migration
- Binding of αvβ1 and αvβ6 integrins to tenascin-C induces epithelial–mesenchymal transition-like change of breast cancer cells
- (2013) D Katoh et al. Oncogenesis
- Tumor Targeting via Integrin Ligands
- (2013) Udaya Kiran Marelli et al. Frontiers in Oncology
- A randomized, double-blind, multicenter, phase 2 study of a human monoclonal antibody to human αν integrins (intetumumab) in combination with docetaxel and prednisone for the first-line treatment of patients with metastatic castration-resistant prostate cancer
- (2012) A. Heidenreich et al. ANNALS OF ONCOLOGY
- Phase Ib safety and pharmacokinetic study of volociximab, an anti-α5β1 integrin antibody, in combination with carboplatin and paclitaxel in advanced non-small-cell lung cancer
- (2012) B. Besse et al. ANNALS OF ONCOLOGY
- Recombinant human endostatin combined with definitive chemoradiotherapy as primary treatment for patients with unresectable but without systemic metastatic squamous cell carcinoma of the oesophagus
- (2012) Z Zhong et al. BRITISH JOURNAL OF RADIOLOGY
- A safety run-in and randomized phase 2 study of cilengitide combined with chemoradiation for newly diagnosed glioblastoma (NABTT 0306)
- (2012) L. Burt Nabors et al. CANCER
- Cancer Stem Cells: Current Status and Evolving Complexities
- (2012) Jane E. Visvader et al. Cell Stem Cell
- The αVβ3/αVβ5 integrin inhibitor cilengitide augments tumor response to melphalan isolated limb perfusion in a sarcoma model
- (2012) Timo L.M. ten Hagen et al. INTERNATIONAL JOURNAL OF CANCER
- Role of monocarboxylate transporters in human cancers: state of the art
- (2012) Céline Pinheiro et al. JOURNAL OF BIOENERGETICS AND BIOMEMBRANES
- β1 Integrin/FAK/cortactin signaling is essential for human head and neck cancer resistance to radiotherapy
- (2012) Iris Eke et al. JOURNAL OF CLINICAL INVESTIGATION
- The interplay of HER2/HER3/PI3K and EGFR/HER2/PLC-γ1 signalling in breast cancer cell migration and dissemination
- (2012) Lydia M Balz et al. JOURNAL OF PATHOLOGY
- RGD-Based Strategies To Target Alpha(v) Beta(3) Integrin in Cancer Therapy and Diagnosis
- (2012) Fabienne Danhier et al. MOLECULAR PHARMACEUTICS
- Building the niche: The role of the S100 proteins in metastatic growth
- (2012) Eugene Lukanidin et al. SEMINARS IN CANCER BIOLOGY
- Concepts of metastasis in flux: The stromal progression model
- (2012) Jonathan P. Sleeman et al. SEMINARS IN CANCER BIOLOGY
- New insights into the mechanisms of organ-specific breast cancer metastasis
- (2012) Girieca Lorusso et al. SEMINARS IN CANCER BIOLOGY
- Cilengitide: The First Anti-Angiogenic Small Molecule Drug Candidate. Design, Synthesis and Clinical Evaluation
- (2011) Carlos Mas-Moruno et al. Anti-Cancer Agents in Medicinal Chemistry
- A randomised, phase II study of intetumumab, an anti-αv-integrin mAb, alone and with dacarbazine in stage IV melanoma
- (2011) S O'Day et al. BRITISH JOURNAL OF CANCER
- ATM-Mediated DNA Damage Signals Mediate Immune Escape through Integrin- v 3-Dependent Mechanisms
- (2011) M. Jinushi et al. CANCER RESEARCH
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- 1-Integrin: A Potential Therapeutic Target in the Battle against Cancer Recurrence
- (2011) D. Barkan et al. CLINICAL CANCER RESEARCH
- Volociximab in cancer
- (2011) Salah Almokadem et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- A phase II, single-arm study of the anti-α5β1 integrin antibody volociximab as monotherapy in patients with platinum-resistant advanced epithelial ovarian or primary peritoneal cancer
- (2011) Katherine M. Bell-McGuinn et al. GYNECOLOGIC ONCOLOGY
- Clinical and pharmacologic evaluation of two dose levels of intetumumab (CNTO 95) in patients with melanoma or angiosarcoma
- (2011) Steven J. O’Day et al. INVESTIGATIONAL NEW DRUGS
- Interstitial guidance of cancer invasion
- (2011) Pavlo G. Gritsenko et al. JOURNAL OF PATHOLOGY
- The Role of Lysyl Oxidase in SRC-Dependent Proliferation and Metastasis of Colorectal Cancer
- (2011) Ann-Marie Baker et al. JNCI-Journal of the National Cancer Institute
- Cancer immunotherapy comes of age
- (2011) Ira Mellman et al. NATURE
- Interactions between cancer stem cells and their niche govern metastatic colonization
- (2011) Ilaria Malanchi et al. NATURE
- Molecular mechanisms and clinical applications of angiogenesis
- (2011) Peter Carmeliet et al. NATURE
- Breast cancer cells produce tenascin C as a metastatic niche component to colonize the lungs
- (2011) Thordur Oskarsson et al. NATURE MEDICINE
- Tumor angiogenesis: molecular pathways and therapeutic targets
- (2011) Sara M Weis et al. NATURE MEDICINE
- 68Ga-NODAGA-RGDyK for αvβ3 integrin PET imaging
- (2011) F. Buchegger et al. NUKLEARMEDIZIN-NUCLEAR MEDICINE
- CD49f and CD61 identify Her2/neu-induced mammary tumor-initiating cells that are potentially derived from luminal progenitors and maintained by the integrin–TGFβ signaling
- (2011) P-K Lo et al. ONCOGENE
- HIF-1-dependent expression of angiopoietin-like 4 and L1CAM mediates vascular metastasis of hypoxic breast cancer cells to the lungs
- (2011) H Zhang et al. ONCOGENE
- Hypoxia-inducible factor 1 is a master regulator of breast cancer metastatic niche formation
- (2011) C. C.-L. Wong et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- A randomized phase 2 study of etaracizumab, a monoclonal antibody against integrin αvβ3, ± dacarbazine in patients with stage IV metastatic melanoma
- (2010) Peter Hersey et al. CANCER
- Integrin Alpha 6 Regulates Glioblastoma Stem Cells
- (2010) Justin D. Lathia et al. Cell Stem Cell
- Extracellular matrix: A gatekeeper in the transition from dormancy to metastatic growth
- (2010) Dalit Barkan et al. EUROPEAN JOURNAL OF CANCER
- Phase II study of Cilengitide (EMD 121974, NSC 707544) in patients with non-metastatic castration resistant prostate cancer, NCI-6735. A study by the DOD/PCF prostate cancer clinical trials consortium
- (2010) Ajjai Alva et al. INVESTIGATIONAL NEW DRUGS
- Phase I/IIa Study of Cilengitide and Temozolomide With Concomitant Radiotherapy Followed by Cilengitide and Temozolomide Maintenance Therapy in Patients With Newly Diagnosed Glioblastoma
- (2010) Roger Stupp et al. JOURNAL OF CLINICAL ONCOLOGY
- Pharmacodynamic (Phase 0) Study Using Etaracizumab in Advanced Melanoma
- (2010) Stergios J. Moschos et al. JOURNAL OF IMMUNOTHERAPY
- Ligand-independent activation of c-Met by fibronectin and α5β1-integrin regulates ovarian cancer invasion and metastasis
- (2010) A K Mitra et al. ONCOGENE
- Hypoxia-Induced Lysyl Oxidase Is a Critical Mediator of Bone Marrow Cell Recruitment to Form the Premetastatic Niche
- (2009) Janine T. Erler et al. CANCER CELL
- Cell Adhesion Molecules: Role and Clinical Significance in Cancer
- (2009) Nektaria Makrilia et al. CANCER INVESTIGATION
- Tumor Self-Seeding by Circulating Cancer Cells
- (2009) Mi-Young Kim et al. CELL
- Matrix Crosslinking Forces Tumor Progression by Enhancing Integrin Signaling
- (2009) Kandice R. Levental et al. CELL
- Interstitial cell migration: integrin-dependent and alternative adhesion mechanisms
- (2009) Samuel Schmidt et al. CELL AND TISSUE RESEARCH
- Integrin α3β1–dependent β-catenin phosphorylation links epithelial Smad signaling to cell contacts
- (2009) Young Kim et al. JOURNAL OF CELL BIOLOGY
- Regulation of 4-integrin expression by epigenetic modifications in the mammary gland and during the epithelial-to-mesenchymal transition
- (2009) X. Yang et al. JOURNAL OF CELL SCIENCE
- Loss of the Tumor Suppressor Gene NF2, Encoding Merlin, Constitutively Activates Integrin-Dependent mTORC1 Signaling
- (2009) M. A. Lopez-Lago et al. MOLECULAR AND CELLULAR BIOLOGY
- Antioxidant and oncogene rescue of metabolic defects caused by loss of matrix attachment
- (2009) Zachary T. Schafer et al. NATURE
- An integrin αvβ3–c-Src oncogenic unit promotes anchorage-independence and tumor progression
- (2009) Jay S Desgrosellier et al. NATURE MEDICINE
- Stimulation of tumor growth and angiogenesis by low concentrations of RGD-mimetic integrin inhibitors
- (2009) Andrew R Reynolds et al. NATURE MEDICINE
- The Integrin Antagonist Cilengitide Activates αVβ3, Disrupts VE-Cadherin Localization at Cell Junctions and Enhances Permeability in Endothelial Cells
- (2009) Gian Carlo Alghisi et al. PLoS One
- Interaction of monocarboxylate transporter 4 with β1-integrin and its role in cell migration
- (2008) Shannon M. Gallagher et al. AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY
- Integrins in breast cancer dormancy
- (2008) STEPHANIE M. PONTIER et al. APMIS
- CYR61 and V 5 Integrin Cooperate to Promote Invasion and Metastasis of Tumors Growing in Preirradiated Stroma
- (2008) Y. Monnier et al. CANCER RESEARCH
- Integrin αvβ3-targeted cancer therapy
- (2008) Zhaofei Liu et al. DRUG DEVELOPMENT RESEARCH
- The tumor microenvironment and its contribution to tumor evolution toward metastasis
- (2008) Girieca Lorusso et al. HISTOCHEMISTRY AND CELL BIOLOGY
- The tumor suppressor gene ARHI regulates autophagy and tumor dormancy in human ovarian cancer cells
- (2008) Zhen Lu et al. JOURNAL OF CLINICAL INVESTIGATION
- Randomized Phase II Study of Cilengitide, an Integrin-Targeting Arginine-Glycine-Aspartic Acid Peptide, in Recurrent Glioblastoma Multiforme
- (2008) David A. Reardon et al. JOURNAL OF CLINICAL ONCOLOGY
- Cancer Cell-Derived Clusterin Modulates the Phosphatidylinositol 3'-Kinase-Akt Pathway through Attenuation of Insulin-Like Growth Factor 1 during Serum Deprivation
- (2008) H. Jo et al. MOLECULAR AND CELLULAR BIOLOGY
- β1 Integrin deletion from the basal compartment of the mammary epithelium affects stem cells
- (2008) Ilaria Taddei et al. NATURE CELL BIOLOGY
- The S100A8–serum amyloid A3–TLR4 paracrine cascade establishes a pre-metastatic phase
- (2008) Sachie Hiratsuka et al. NATURE CELL BIOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search